Specific prevention and education strategies are needed to address breast cancer in Mexican-origin women in this country, according to a study at The University of Texas MD Anderson Cancer Center, which was published online in the journal Cancer…
No Comments »
Filed under: Women's Health
When breast cancer surgeons regularly confer with plastic surgeons prior to surgery, their patients are more likely to have reconstruction, according to a new study led by researchers at the University of Michigan Comprehensive Cancer Center. Where a woman goes for breast cancer treatment can vary widely - ranging from small private practices to large [...]
No Comments »
Filed under: Women's Health
A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient…
No Comments »
Filed under: Women's Health
Women with the inherited mutations of the BRCA1 or BRCA2 genes who had preventive (prophylactic) breast removal (mastectomy) or the removal of the fallopian tubes and ovaries (salpingo-oophorectomy) were found to have a significantly lower risk of developing ovarian and breast cancers, says a study published in JAMA (Journal of the American Medical Association), September [...]
No Comments »
Filed under: Women's Health
Eisai Inc. announced today that it has received notification from the U.S. Food and Drug Administration (FDA) that the agency expects to complete priority review of the eribulin mesylate New Drug Application (NDA) for locally advanced or metastatic breast cancer on or before December 30, 2010, which is a three month extension from the original [...]
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The Food and Drug Administration turned down a request for accelerated approval of Roche-Genentech’s trastuzumab-DM1 for treatment of HER2-positive breast cancer.
No Comments »
Filed under: General Health News
In its review of the BLA, the FDA stated the T-DM1 trials did not meet the standard for accelerated approval because all available treatment choices approved for metastatic breast cancer, regardless of HER2 status, had not been exhausted in the study population.
No Comments »
Filed under: Pharmacy News
The Food and Drug Administration (FDA) has issued a Refuse to File letter for accelerated approval of Roche’s trastuzumab-DM1 (T-DM1) Biologics License Application, which was submitted in July 2010. Roche had requested accelerated approval for T-DM1 based on the results of a single-arm Phase II study. In that study one third of advanced HER2 positive [...]
No Comments »
Filed under: Pharmacy News
Starting in September, President Obama’s Affordable Care Act will go into effect. The act mandates free preventative services such as cholesterol or breast cancer screenings and tetanus shots…
No Comments »
Filed under: Men's Health
Starting in September, President Obama’s Affordable Care Act will go into effect. The act mandates free preventative services such as cholesterol or breast cancer screenings and tetanus shots. But the question is, will doctors and patients take advantage of these new preventative services? “Unfortunately, thanks to our American healthcare system, we have been programmed to [...]
No Comments »
Filed under: Pharmacy News
